/
AGYTF
$0.14+$0.01 (+7.69%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.09 – $0.14
100% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.21
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $68.3M | $73.7M | $78.2M | $84.3M | $72.8M | $59.6M | $55.2M | $75.6M |
| Cost of revenue | $17.0M | $18.4M | $20.2M | $22.1M | $23.3M | $26.3M | $25.5M | $41.1M |
| Gross profit | $51.3M | $55.3M | $58.0M | $62.2M | $49.5M | $33.2M | $29.7M | $34.5M |
| Gross margin | 75.1% | 75.1% | 74.2% | 73.8% | 68.0% | 55.8% | 53.9% | 45.7% |
| R&D | $16.0M | $7.0M | $5.8M | $12.9M | $15.7M | $20.1M | $22.9M | $15.4M |
| Operating income | −$6.7M | $4.4M | $8.3M | $4.0M | −$12.2M | −$39.7M | −$35.3M | −$28.2M |
| EBITDA | −$4.6M | $6.6M | $12.5M | $8.3M | −$7.8M | −$35.1M | −$30.7M | −$40.4M |
| Net income | −$7.5M | $3.5M | $7.1M | $2.9M | −$13.8M | −$43.1M | −$40.2M | −$55.1M |
| Net margin | -11.0% | 4.7% | 9.0% | 3.4% | -18.9% | -72.3% | -72.9% | -72.9% |
| EPS (diluted) | -0.01 | 0.00 | 0.01 | 0.00 | -0.01 | -0.04 | -0.01 | -0.01 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $83M | $-0.01 | $-0.01–$-0.01 | 1 |
| 2027 | $341M | $0.01 | $0.01–$0.01 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
ALLERGY THERAPEUTICS PLC
ALLERGY THERAPEUTICS PLC
Held by traders on TradeandTell
No one on the platform currently holds AGYTF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AGYTF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AGYTF yet.